http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2502494-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b82f96f476d23a7668947a83cdaefcc4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01022 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2006-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41dfff89ddc3fd0aaabaac64121e9b55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006fb7f2b38a78c9e336472310c931a3 |
| publicationDate | 2012-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2502494-A2 |
| titleOfInvention | Novel alpha-galactosidases |
| abstract | There is disclosed a method of modifying red blood cells, comprising: n(i) suspending group B or group AB erythrocytes in a buffer solution having a neutral pH, n(ii) incubating the erythrocytes of step(i) with an enzyme having α-galactosidase activity, and n(iii) isolating the converted erythrocytes of step(ii) from the enzyme and the enzymatically-cleaved immunodominant galactose residues, n nthereby cleaving the branched immunodominant B epitopes on the group B or group AB erythrocyte as determined by serological typing or hemagglutination assays. |
| priorityDate | 2005-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 445.